2 completed, 2 not yet recruiting, 1 recruiting, 1 unknown. 7 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 7 | Completed 2, Not yet recruiting 2, Recruiting 1, Unknown 1, Withdrawn 1 |
Follow Bacillaceae Infections: new trials by email Literature Review of Bacillaceae Infections trials Research Report on Bacillaceae Infections
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Benefit and Safety of Raxibacumab in Patients With Symptomatic Inhalational Anthrax in a Mass Exposure Scenario Sample Collection - Infections, Bacterial | Phase 4 | Not yet recruiting | Emergent BioSolutions | 100 | 2027-01-01 | 2026-02-06 |
| SGLT2 Inhibitor Utilization Re-perfusion Therapy Canagliflozin 100mg - Acute Ischemic Stroke From Large Vessel Occlusion | Phase 4 | Not yet recruiting | Taichung Veterans General Hospital | 150 | 2026-04-13 | 2026-04-03 |
| Activated CHARcoal in Poisoned Patient - Pilot Trial Activated Charcoal, No activated charcoal - Charcoal, Decontamination, Poisoning | Phase 4 | Recruiting | Laval University | 100 | 2025-07-16 | 2026-01-29 |
| An Open Label Field Study of Anthim (Obiltoxaximab) in Subjects Exposed to B. Anthracis Collection of samples, Obiltoxaximab - Infection, Bacterial, Anthrax | Phase 4 | Unknown | Elusys Therapeutics | 100 | 2023-12-01 | 2023-07-14 |
| Activates Charcoal for Patients Undergoing Invasive Procedure Delayed Due to Direct Oral Anticoagulants Activated Charcoal - Anticoagulants; Circulating, Hemorrhagic Disorder | Phase 4 | Withdrawn | University Hospital, Angers | 2014-07-18 | 2025-10-07 | |
| Assessment of the Immunogenicity and Safety of a Dose-Sparing BioThrax® AVA Schedule BioThrax® - Bacillus Anthracis (Anthrax) | Phase 4 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 328 | 2012-07-01 | 2014-05-28 |
| Anthrax Vaccine Clinical Trial to Assess Dose Reduction and Route Change Anthrax Vaccine Adsorbed, Saline injection - Healthy | Phase 4 | Completed | Centers for Disease Control and Prevention | 1564 | 2002-05-01 | 2024-05-29 |
Anthrax (7) · Bacterial Infections (2) · Hemorrhagic Disorders (1) · Poisoning (1)
Bacterial Infections and Mycoses (7) · Gram-Positive Bacterial Infections (7) · Infections (7) · Bacterial Infections (5) · Chemically-Induced Disorders (1) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1)
Biothrax (2) · Charcoal (2) · Anthrax Vaccines (1) · Canagliflozin (1) · Sodium Chloride (1) · Specimen Handling (1) · obiltoxaximab (1)
Centers for Disease Control and Prevention (1) · Elusys Therapeutics (1) · Emergent BioSolutions (1) · Laval University (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1) · Taichung Veterans General Hospital (1) · University Hospital, Angers (1)
United States (2) · Canada (1) · France (1)
Bojan Drobic, PhD (1) · Jennifer Wright, DVM (1) · Maude St-Onge, MD PhD FRCPC (1) · Po-Lin Chen (1) · Thomas Moumneh, Dr (1) · Timothy S. Leach, MD, MPH (1)